A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin

计划入组 145 人 · 首次发布于 2007 年 4 月 4 日

X-linked Hypophosphatemia and FGF21

计划入组 39 人 · 首次发布于 2018 年 7 月 24 日

Role of FGF21 in Breast Cancer

计划入组 84 人 · 首次发布于 2025 年 8 月 8 日

FGF21(Kriya)

AAV8-FGF21

GLP-1/FGF21 dual agonist

Doer Biologics Completes Phase 2 Enrollment for Novel Tri-Specific Agonist Targeting Severe Hypertriglyceridemia

Doer Bio Doses First Patient in Phase 2 Trial of DR10624 for Severe Hypertriglyceridemia

Novel Pipeline Drugs Show Promise in Treating Severe Hypertriglyceridemia